• NextPlat posted a net loss of USD 1.13 million, narrowing from USD 1.94 million a year earlier; loss attributable to common stockholders narrowed to USD 1.12 million, or USD 0.42 per share.
• Revenue fell 29% to USD 9.86 million versus year-ago quarter, as pharmacy prescription revenue, net dropped 50% to USD 4.78 million.
• Pharmacy contract revenue rose 31% to USD 1.87 million, while e-Commerce revenue increased 6% to USD 3.2 million.
• Operating cash outflow widened to USD 2.58 million from USD 2.06 million, leaving cash at USD 11.01 million at quarter-end.
• Management cited lower reimbursement rates and reduced prescription volume as drivers of the pharmacy prescription revenue decline, while pointing to new contracted medication fulfillment services for the contract revenue increase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-017156), on May 15, 2026, and is solely responsible for the information contained therein.